Related Experiment Video
Updated: Jun 13, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Formoterol fumarate inhalation solution (Perforomist) for COPD
1University of Minnesota, Pulmonary 111N, One Veterans Drive, Minneapolis, MN 55417, USA. rubin004@umn.edu
Expert Review of Clinical Immunology
|May 19, 2010
Summary
Formoterol fumarate effectively treats chronic obstructive pulmonary disease (COPD) by providing rapid and sustained bronchodilation. This medication improves lung function, reduces symptoms, and decreases the need for rescue inhalers, especially when combined with anticholinergics.
Area of Science:
- Pulmonology
- Pharmacology
Background:
- Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide.
- Effective bronchodilator therapy is essential for managing COPD symptoms and improving lung function.
Purpose of the Study:
- To review the efficacy and benefits of formoterol fumarate in the treatment of COPD.
- To highlight the advantages of formoterol fumarate inhalation solution for specific patient populations.
Main Methods:
- Review of published studies on formoterol fumarate in COPD patients.
- Analysis of clinical outcomes including bronchodilation, symptom relief, and rescue medication use.
Main Results:
- Formoterol fumarate demonstrates rapid onset and sustained 12-hour bronchodilation, enhancing patient compliance.
- Long-term use improves lung function (FEV1) and reduces hyperinflation, correlating with symptom relief.
- Combination therapy with anticholinergics, particularly tiotropium, offers superior benefits compared to monotherapy.
Conclusions:
- Formoterol fumarate is an effective treatment for moderate to severe COPD, offering significant symptom relief and improved lung function.
- The availability of formoterol fumarate inhalation solution expands treatment options for patients preferring nebulizer therapy.
- Combination therapy with anticholinergics provides additive benefits in managing COPD.
Related Concept Videos
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:24Antiasthma Drugs: Methylxanthines
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation